NUCLEAR RECEPTOR BINDING SET DOMAIN PROTEINS: ORCHESTRATING ANTI-TUMOR IMMUNITY AND THE PROMISE OF TARGETED DEGRADATION THERAPIES. European Journal of Emerging Molecular Sciences, [S. l.], v. 1, n. 01, p. 69–79, 2024. Disponível em: https://parthenonfrontiers.com/index.php/ejems/article/view/31. Acesso em: 15 jan. 2026.